Health-related quality of life across menopausal stages among middle-aged Korean women
- 28 January 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 32 (4) , 337-345
Abstract
Objectives: We examined the health-related quality of life (HRQoL) during menopause transition (MT) among middle-aged Korean women. Methods: This cross-sectional study comprised 2,290 middle-aged women who completed web-based questionnaires between 2020 and 2022. Based on self-reported menstrual cycle patterns, menopause status was classified as premenopausal, early or late transition, or postmenopausal. HRQoL was assessed using the Patient-Reported Outcomes Measurement Information system, with all 29 items scored using a T-score metric. Multiple linear regression analyses were performed to investigate whether HRQoL varied based on MT stages. Antimüllerian hormone levels were used as an objective measure instead of self-reported menstrual status in the sensitivity analysis. Logistic regression models were used to estimate the prevalence ratios for moderate or severe HRQoL symptoms across menopausal stages. Results: The mean T-scores for anxiety, depression, and pain interference and intensity were significantly higher with advancing menopausal stage. Anxiety, depression, sleep disturbances, pain interference, and intensity were significantly and linearly positively correlated with MT stages after adjusting for potential confounders. Physical function significantly worsened in the late transition stage compared with premenopausal status ( β = −1.51 [95% CI, −2.72 to −0.31] in late MT and β = −1.92 [95% CI, −3.46 to −0.37] in postmenopause, P for trend = 0.007). However, no significant trends were observed in the sensitivity analysis using antimüllerian hormone levels. Women with moderate or severe symptoms in all domains except physical function had significantly higher prevalence ratios according to MT. Conclusions: Overall HRQoL was lower with advancing menopausal stages. All symptoms should be monitored to control early transition symptoms. Thus, women undergoing MT should consistently assess and manage not only menopausal symptoms but also the overall quality of their health to prevent both menopause-specific and nonspecific conditions and their consequences.Keywords
This publication has 34 references indexed in Scilit:
- PROMIS® Adult Health Profiles: Efficient Short-Form Measures of Seven Health DomainsValue in Health, 2019
- Duration of Menopausal Vasomotor Symptoms Over the Menopause TransitionJAMA Internal Medicine, 2015
- Quality of life in female cancer survivors: is it related to ovarian reserve?Quality of Life Research, 2013
- Factors associated with the age of natural menopause and menopausal symptoms in Chinese womenMaturitas, 2012
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008Journal of Clinical Epidemiology, 2010
- Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of lifeMaturitas, 2009
- Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening programMaturitas, 2007
- Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndromeArchives of Gynecology and Obstetrics, 2006
- Does the menopausal transition affect health-related quality of life?The American Journal of Medicine, 2005
- A menopause-specific quality of life questionnaire: development and psychometric propertiesMaturitas, 1996